Ipsen SA (EURONEXT:IPN) - Share price - Overview

Stock Report

Ipsen SA IPN

Last Price
133.70

Day Change
-0.25|-0.19%

As of 18/05/2018
17:35:08 CEST | EUR
Minimum 15 Minutes Delay.

Last Close133.95
Day Range133.50 - 135.10
Mkt Cap11.05Bil
52-Wk Range97.24 - 137.35
Yield %0.64
ISINFR0010259150
Volume71,655
P/E41.14
P/S5.52
P/CF26.25

Share Price

Financials
201520162017
More ...
Income Statement
Revenue1,520.201,671.102,011.70
Operating Income322.40371.10503.60
Net Income189.90225.90272.30
Basic EPS2.312.743.30
Avg. Diluted Shares Outstanding838383
Balance Sheet
Current Assets809.901,050.401,016.40
Non Current Assets1,128.101,373.102,055.60
Total Assets1,938.002,423.503,072.00
Current Liabilities461.50561.30941.80
Total Liabilities---
Total Equity1,222.501,358.901,525.40
Cash Flow
Operating Cash Flow223.60317.80422.90
Capital Expenditure-75.20-372.30-240.80
Free Cash Flow148.40-54.50182.10

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

5,401
Key Stats
More ...
Price/Earning TTM40.59
Price/Book7.26
Price/Sales TTM5.53
Rev Growth (3 year avg)14.72
EPS Growth (3 year avg)-
Operating Margin % TTM25.03
Net Margin % TTM13.54
ROE TTM18.88
Debt/Equity0.20
Dividends
PreviousLatest
More ...
Declared Date20/04/1715/02/18
Ex-Div09/06/1704/06/18
Paid13/06/1706/06/18
Amnt0.851.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.